GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Gross Margin %

Wai Yuen Tong Medicine Holdings (HKSE:00897) Gross Margin % : 47.73% (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Wai Yuen Tong Medicine Holdings's Gross Profit for the six months ended in Sep. 2023 was HK$324 Mil. Wai Yuen Tong Medicine Holdings's Revenue for the six months ended in Sep. 2023 was HK$679 Mil. Therefore, Wai Yuen Tong Medicine Holdings's Gross Margin % for the quarter that ended in Sep. 2023 was 47.73%.


The historical rank and industry rank for Wai Yuen Tong Medicine Holdings's Gross Margin % or its related term are showing as below:

HKSE:00897' s Gross Margin % Range Over the Past 10 Years
Min: 40.13   Med: 42.16   Max: 49.12
Current: 49.12


During the past 13 years, the highest Gross Margin % of Wai Yuen Tong Medicine Holdings was 49.12%. The lowest was 40.13%. And the median was 42.16%.

HKSE:00897's Gross Margin % is ranked better than
54.1% of 987 companies
in the Drug Manufacturers industry
Industry Median: 47 vs HKSE:00897: 49.12

Wai Yuen Tong Medicine Holdings had a gross margin of 47.73% for the quarter that ended in Sep. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Wai Yuen Tong Medicine Holdings was 2.10% per year.


Wai Yuen Tong Medicine Holdings Gross Margin % Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Gross Margin % Chart

Wai Yuen Tong Medicine Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.13 45.36 40.17 40.99 47.56

Wai Yuen Tong Medicine Holdings Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.95 40.14 44.25 50.51 47.73

Competitive Comparison of Wai Yuen Tong Medicine Holdings's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wai Yuen Tong Medicine Holdings's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's Gross Margin % falls into.



Wai Yuen Tong Medicine Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Wai Yuen Tong Medicine Holdings's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=611.8 / 1286.428
=(Revenue - Cost of Goods Sold) / Revenue
=(1286.428 - 674.651) / 1286.428
=47.56 %

Wai Yuen Tong Medicine Holdings's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=324 / 678.804
=(Revenue - Cost of Goods Sold) / Revenue
=(678.804 - 354.777) / 678.804
=47.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Wai Yuen Tong Medicine Holdings  (HKSE:00897) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Wai Yuen Tong Medicine Holdings had a gross margin of 47.73% for the quarter that ended in Sep. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Wai Yuen Tong Medicine Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Traded in Other Exchanges
N/A
Address
39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
Executives
Wang On Group Limited 2501 Other
Tang Ching Ho 2501 Other
Yau Yuk Yin 2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines